| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,164 |
1,920 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,889 |
1,704 |
$68K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,969 |
1,200 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
159 |
150 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
45 |
40 |
$3K |
| 90461 |
|
73 |
63 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
67 |
61 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
72 |
70 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
30 |
26 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
113 |
67 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
594 |
525 |
$762.23 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
25 |
$517.08 |
| 99174 |
|
26 |
24 |
$405.73 |
| 90670 |
|
12 |
12 |
$257.99 |
| 90688 |
|
25 |
24 |
$79.50 |
| 90686 |
|
81 |
76 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |